"Use of a novel tapered, scoring balloon to treat juxta-anastomotic stenosis in AV fistula"
作者全名:"Li, Xiangjie; Wang, Zhe; Zhao, Xia; Sun, Hao; Fu, Qining"
作者地址:"[Li, Xiangjie; Wang, Zhe; Zhao, Xia; Sun, Hao; Fu, Qining] Chongqing Med Univ, Affiliated Hosp 1, Dept Vasc Surg, 1 Youyi St, Chongqing 400016, Peoples R China"
通信作者:"Fu, QN (通讯作者),Chongqing Med Univ, Affiliated Hosp 1, Dept Vasc Surg, 1 Youyi St, Chongqing 400016, Peoples R China."
来源:JOURNAL OF VASCULAR ACCESS
ESI学科分类:CLINICAL MEDICINE
WOS号:WOS:001062359800001
JCR分区:Q3
影响因子:1.6
年份:2023
卷号:
期号:
开始页:
结束页:
文献类型:Article; Early Access
关键词:Arteriovenous fistula; percutaneous transluminal angioplasty; balloon
摘要:"Background: Juxta-anastomotic stenosis, the most common lesion in arteriovenous fistula, creates a dilemma for optimal balloon size choosing during PTA. Objectives: To descript the effect of a novel tapered scoring balloon catheter (DK Medtech, Suzhou, China) which has a conical shape with an increasing diameter from the front part of the balloon to the end, and three non-slip elements attached on the surface of the balloon. Research design: Case series of 10 patients used this balloon catheter was retrospectively analyzed. Subjects: Patients with juxta-anastomotic stenosis. Measures: A retrospective review of 10 cases using the novel tapered, scoring balloon catheter in our center was performed. Results: All cases were clinical technique success. The average total procedure time was 16.7 min with 2:14 of fluoroscopy time. No complications such as vascular rupture or dissection occurred. The primary patency rates at 6 and 12 month were 80% and 50% separately. Conclusions: This tapered scoring balloon provides an economical, safe, and efficient management for juxta-anastomotic stenosis."
基金机构:Chongqing Science and Technology Bureau; Health Commission joint medical research project [2021MSXM256]
基金资助正文:"The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was supported by Chongqing Science and Technology Bureau and Health Commission joint medical research project (2021MSXM256)."